Annual report pursuant to Section 13 and 15(d)

Investment (Tables)

v3.22.4
Investment (Tables)
12 Months Ended
Sep. 30, 2022
Investment  
Schedule of carrying value of the Company's total investment in DepYmed

As of September 30, 

    

2022

    

2021

Carrying value of DepYmed common shares

$

$

Fair value of DepYmed preferred shares assumed in connection with acquisition of Ohr

 

99,020

DepYmed preferred shares received in sale of intellectual property

316,724

Total Investment

$

$

415,744